Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-08-22

Clinical Trial Update: Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating [Phase 2]

View source ↗

Summary

Completed Phase 2 feasibility trial evaluating intra-dermal insulin injections and their impact on post-meal blood glucose in people with Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Becton, Dickinson and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED